Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 39 articles: HTML format Text format

Single Articles

January 2012
1. GOLDSTEIN MJ , Kohrt HE, Houot R, Varghese B, et al
   Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137 Expressing Regulatory T Cells.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
2. SOMMERMANN T , O'Neill K, Plas DR, Cahir-McFarland E, et al
   IKK{beta} and NF{kappa}B transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
3. DONDOSSOLA E , Gasparri AM, Colombo B, Sacchi A, et al
   Chromogranin A restricts drug penetration and limits the ability of NGR-TNF to enhance chemotherapeutic efficacy.
   Cancer Res. 2011;71:5881-90.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. KUMMAR S , Chen A, Ji J, Zhang Y, et al
   Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.
   Cancer Res. 2011;71:5626-34.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PRITCHARD JR , Gilbert LA, Meacham CE, Ricks JL, et al
   Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response.
   Cancer Res. 2011;71:5850-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
6. GILBERT LA , Hemann MT
   Chemotherapeutic resistance: surviving stressful situations.
   Cancer Res. 2011;71:5062-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. COLOFF JL , Macintyre AN, Nichols AG, Liu T, et al
   Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.
   Cancer Res. 2011;71:5204-13.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
8. MEHTA H , Gao Q, Galet C, Paharkova V, et al
   IGFBP-3 is a Metastasis Suppression Gene in Prostate Cancer.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PURDUE MP , Lan Q, Bagni R, Hocking WG, et al
   Pre-diagnostic serum levels of cytokines and other immune markers and risk of non-Hodgkin lymphoma.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
10. CRAIG VJ , Cogliatti SB, Rehrauer H, Wundisch T, et al
    Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis.
    Cancer Res. 2011;71:3616-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. DESTOUCHES D , Page N, Hamma-Kourbali Y, Machi V, et al
    A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.
    Cancer Res. 2011;71:3296-305.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
12. SCUTO A , Kujawski M, Kowolik C, Krymskaya L, et al
    STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
13. KRETZNER L , Scuto A, Dino PM, Kowolik CM, et al
    Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and micro-RNA levels.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. PEI XH , Bai F, Li Z, Smith MD, et al
    Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis.
    Cancer Res. 2011;71:2969-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. LEE JC , Hayman E, Pegram HJ, Santos E, et al
    In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy.
    Cancer Res. 2011;71:2871-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. STAGG J , Divisekera U, Duret H, Sparwasser T, et al
    CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
    Cancer Res. 2011;71:2892-900.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. NAYLOR TL , Tang H, Ratsch BA, Enns A, et al
    Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas.
    Cancer Res. 2011;71:2643-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
18. MIYAGAKI T , Sugaya M, Murakami T, Asano Y, et al
    CCL11-CCR3 Interactions Promote Survival of Anaplastic Large Cell Lymphoma Cells via ERK1/2 Activation.
    Cancer Res. 2011;71:2056-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
19. VALIS K , Prochazka L, Boura E, Chladova J, et al
    Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner.
    Cancer Res. 2011;71:946-54.
    PubMed     Text format     Related articles   
    
    
    
    
20. SCHIAVONI G , Sistigu A, Valentini M, Mattei F, et al
    Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.
    Cancer Res. 2011;71:768-78.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
21. HU W , Ge X, You T, Xu T, et al
    Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. CIFALDI L , Lo Monaco E, Forloni M, Giorda E, et al
    NK cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. MORITO N , Yoh K, Maeda A, Nakano T, et al
    A novel transgenic mouse model of the human multiple myeloma chromosomal translocation t(14;16)(q32;q23).
    Cancer Res. 2011;71:339-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
24. DURR C , Pfeifer D, Claus R, Schmitt-Graeff A, et al
    CXCL12 Mediates Immunosuppression in the Lymphoma Microenvironment after Allogeneic Transplantation of Hematopoietic Cells.
    Cancer Res. 2010;70:10170-10181.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. RAIA V , Schilling M, Bohm M, Hahn B, et al
    Dynamic Mathematical Modeling of IL13-induced Signaling in Hodgkin and Primary Mediastinal B-cell Lymphoma Allows Prediction of Therapeutic Targets.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
26. MANDAL PK , Schneider M, Kolle P, Kuhlencordt P, et al
    Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation.
    Cancer Res. 2010;70:9505-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
27. CONTAG CH , Sikorski R, Negrin R, Schmidt T, et al
    Definition of an enhanced immune cell therapy in mice that can target stem-like lymphoma cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
28. CHEUNG KJ , Johnson N, Affleck J, Severson T, et al
    Acquired TNFRSF14 mutations in follicular lymphoma are associated with inferior prognosis.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. ZAPPASODI R , Pupa SM, Ghedini GC, Bongarzone I, et al
    Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ROSSI EA , Rossi DL, Stein R, Goldenberg DM, et al
    A Bispecific Antibody-IFN{alpha}2b Immunocytokine Targeting CD20 and HLA-DR Is Highly Toxic to Human Lymphoma and Multiple Myeloma Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. PETERSON QP , Hsu DC, Novotny CJ, West DC, et al
    Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound.
    Cancer Res. 2010;70:7232-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
32. LAGARRIGUE F , Dupuis-Coronas S, Ramel D, Delsol G, et al
    Matrix Metalloproteinase-9 Is Upregulated in Nucleophosmin-Anaplastic Lymphoma Kinase-Positive Anaplastic Lymphomas and Activated at the Cell Surface by the Chaperone Heat Shock Protein 90 to Promote Cell Invasion.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. TANAKA Y , Nakasone H, Yamazaki R, Sato K, et al
    Single-Cell Analysis of T-Cell Receptor Repertoire of HTLV-1 Tax-Specific Cytotoxic T Cells in Allogeneic Transplant Recipients with Adult T-Cell Leukemia/Lymphoma.
    Cancer Res. 2010;70:6181-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. DIERKS C , Adrian F, Fisch P, Ma H, et al
    The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.
    Cancer Res. 2010;70:6193-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
35. CHEN R , Chubb S, Cheng T, Hawtin RE, et al
    Responses in Mantle Cell Lymphoma Cells to SNS-032 Depend on the Biological Context of Each Cell Line.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. SHAH MY , Vasanthakumar A, Barnes NY, Figueroa ME, et al
    DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.
    Cancer Res. 2010;70:5840-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. RYAN SO , Turner MS, Gariepy J, Finn OJ, et al
    Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses.
    Cancer Res. 2010;70:5788-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. CREPIN R , Goenaga AL, Jullienne B, Bougherara H, et al
    Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
    Cancer Res. 2010;70:5497-506.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. CARPENTER RD , Natarajan A, Lau EY, Andrei M, et al
    Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas.
    Cancer Res. 2010;70:5448-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: